A global deep-tech artificial intelligence company acquired by BioNTech in 2023. Specializing in reinforcement learning and generative models, it builds decision-making AI systems for biopharma, genomics, and logistics. Its African operations focus on accelerating AI-driven drug discovery, protein design, and local tech ecosystem development.
Key Achievement: Acquired by BioNTech for ~$700M. Co-developed an early warning system for COVID-19 variants with 100% coverage of critical variants. Office in Nairobi brings East African presence.